NEWS
August 16, 2011 | By Rosie Mestel, Los Angeles Times / For the Booster Shots blog
Addiction is “not simply a behavioral problem involving too much alcohol, drugs, gambling or sex,” the American Society of Addiction Medicine declared this week. Instead, the society notes, “Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry.” In other words, addiction is not just about the act of raising a bottle to the lips, drawing deeply on a cigarette or bingeing guiltily in chocolate bars in private. There just might be something amiss in your head that compels you to behave that way. “The disease is about brains, not drugs.
SCIENCE
February 6, 2013 | By Joseph Serna, Los Angeles Times
As baby boomers enter their golden years, the number of people afflicted with Alzheimer's disease is expected to reach 13.8 million by 2050 - millions more than previously anticipated, according to a new study in the journal Neurology. If researchers can't find a way to reduce the prevalence of the brain disease, the cost to care for all of these patients could top $1 trillion a year, experts say. Alzheimer's is a progressive brain disease that damages patients' memory and cognitive skills, ultimately leaving them unable to care for themselves.
NEWS
November 2, 2010 | By Shari Roan, Los Angeles Times
Public perception of mental illness and addiction has changed significantly -- and for the good -- in the last 15 years. That doesn't mean, however, that people feel comfortable working or living near or being friends with someone with mental illness, according to a major new survey. The study compared people's responses to vignettes involving mental illness and addiction to gauge public understanding of the illness and feelings toward those who are ill or addicted. The surveys took place in 1996 and 2006.
BUSINESS
October 18, 2005 | From Associated Press
The two pharmaceutical companies that make the drug Tysabri said they had found no new cases of a rare brain disease among nearly 1,500 people who took the suspended drug to treat rheumatoid arthritis and Crohn's disease. Elan Corp. of Dublin, Ireland, and Biogen Idec Inc. of Cambridge, Mass., said their screening of people who took Tysabri in clinical trials for both diseases had turned up no new cases of progressive multifocal leukoencephalopathy.
CALIFORNIA | LOCAL
February 10, 2012 | By Thomas Curwen, Los Angeles Times
More than a year after the diagnosis, Maureen Bryant had grown accustomed to making excuses for her husband. When Stu stood behind a tattooed woman in line at Panda Express, and said loudly, "Wow, that's a lot of tattoos," Moe stepped between him and the woman and apologized. When he repeatedly wandered into the house that was being built down the street - despite the "No Trespassing" sign and the fence - she explained to the owner that he was just curious. Possibly the most embarrassing episode occurred when they were coming home from dinner, and she dashed into a mini-mart at a marina in Oxnard to buy milk.
NEWS
December 1, 1997 | From Times Staff and Wire Reports
Researchers said they had found a way to sneak vitamin C past the so-called blood-brain barrier, the gatekeeper that protects the brain from infection. They said if their method works in people, it could offer a new approach to treating Alzheimer's disease and other diseases that come from damage to brain cells. This is because vitamin C is a powerful antioxidant, working to prevent damage caused by everyday life that leads to diseases such as cancer, heart disease and perhaps even Alzheimer's.